Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

579 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase 2 Study of Afatinib Alone or Combined With Bevacizumab in Chemonaive Patients With Advanced Non-Small-Cell Lung Cancer Harboring EGFR Mutations: AfaBev-CS Study Protocol.
Ninomiya T, Ishikawa N, Inoue K, Kubo T, Yasugi M, Shibayama T, Maeda T, Fujitaka K, Kodani M, Yokoyama T, Kuyama S, Ochi N, Ueda Y, Miyoshi S, Kozuki T, Amano Y, Kubota T, Sugimoto K, Bessho A, Ishii T, Watanabe K, Oze I, Hotta K, Kiura K. Ninomiya T, et al. Among authors: kiura k. Clin Lung Cancer. 2019 Mar;20(2):134-138. doi: 10.1016/j.cllc.2018.10.008. Epub 2018 Nov 1. Clin Lung Cancer. 2019. PMID: 30514667
Gingival metastasis in lung cancer.
Tanaka M, Hiraki A, Ueoka H, Bessho A, Kiura K, Takigawa N, Kodani T, Miyatake K, Hamada N, Kishimoto T, Tanimoto M, Harada M. Tanaka M, et al. Among authors: kiura k. Oncol Rep. 2002 May-Jun;9(3):571-4. Oncol Rep. 2002. PMID: 11956629
A phase III randomized trial comparing vindesine and cisplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer: long-term follow-up results and analysis of prognostic factors.
Kodani T, Ueoka H, Kiura K, Tabata M, Takigawa N, Segawa Y, Moritaka T, Hiraki S, Harada M, Tanimoto M. Kodani T, et al. Among authors: kiura k. Lung Cancer. 2002 Jun;36(3):313-9. doi: 10.1016/s0169-5002(02)00008-9. Lung Cancer. 2002. PMID: 12009244 Clinical Trial.
[Combination chemotherapy with carboplatin and etoposide for elderly patients aged 76 years or older with small cell lung cancer].
Tada A, Ueoka H, Kiura K, Tabata M, Takemoto M, Yamane H, Hiyama J, Aoe K, Shibayama T, Kamei H, Kawahara S, Harita S, Sato T, Kobayashi M, Eguchi K, Hiraki S, Hiraki Y, Tanimoto M. Tada A, et al. Among authors: kiura k. Gan To Kagaku Ryoho. 2002 May;29(5):751-6. Gan To Kagaku Ryoho. 2002. PMID: 12040679 Clinical Trial. Japanese.
Phase I/II study of altered schedule of cisplatin and etoposide administration and concurrent accelerated hyperfractionated thoracic radiotherapy for limited-stage small-cell lung cancer.
Segawa Y, Ueoka H, Kiura K, Tabata M, Takigawa N, Hiraki Y, Watanabe Y, Yonei T, Moritaka T, Hiyama J, Hiraki S, Tanimoto M, Harada M; Okayama Lung Cancer Study Group. Segawa Y, et al. Among authors: kiura k. Lung Cancer. 2003 Jul;41(1):13-20. doi: 10.1016/s0169-5002(03)00139-9. Lung Cancer. 2003. PMID: 12826307 Clinical Trial.
579 results